Zocor vs. Leqvio

See how Zocor and Leqvio compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Zocor is a daily oral statin pill, while Leqvio is a subcutaneous injection given just twice a year after two starter doses three months apart.

  • Zocor has over three decades of safety data and is sold as an inexpensive generic, while Leqvio is a newer siRNA drug given in a clinic setting.

  • Both lower LDL cholesterol, but Leqvio is typically added on top of a statin rather than used in place of one.

Zocor vs. Leqvio Drug Summary

Zocor

Zocor (simvastatin) is a statin that lowers LDL cholesterol by blocking a liver enzyme the body uses to make cholesterol. It's taken as a tablet once daily, with doses ranging from 10 mg to 80 mg. It's approved to treat high cholesterol and to reduce the risk of heart attack, stroke, and death in people with heart disease or diabetes.

Leqvio

Leqvio (inclisiran) is a small interfering RNA (siRNA) drug that lowers LDL cholesterol by blocking the liver's production of PCSK9, a protein that limits cholesterol clearance. It's given as an injection, starting with two doses three months apart, then just one injection every six months after that. It's approved as an add-on to diet and exercise for adults and certain adolescents with high cholesterol or familial hypercholesterolemia.

Zocor vs. Leqvio Side Effects

Zocor

Most common
Upper respiratory infection (up to 9%)
Headache (up to 7%)
Abdominal pain (up to 7%)

Leqvio

Most common
Injection site reaction (up to 3%)
Arthralgia (up to 3%)
Bronchitis (up to 3%)

Zocor vs. Leqvio Dosage

Zocor

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily At the start
Maximum dose 80 mg once daily If needed
Dose changes 3 increases As tolerated

Leqvio

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 284 mg injection Day 1
Maximum dose 284 mg injection Same as starting
Dose changes None Fixed dose

Zocor vs. Leqvio Indications

Zocor

Zocor is FDA-approved to lower LDL cholesterol in adults with high cholesterol, including inherited forms, and to reduce the risk of heart attack, stroke, and death in people with existing heart disease or diabetes at high risk. It's also approved for children as young as 10 with heterozygous familial hypercholesterolemia.

  • Lower LDL cholesterol in adults with high cholesterol

  • Heterozygous familial hypercholesterolemia (ages 10+)

  • Add-on therapy for homozygous familial hypercholesterolemia

Leqvio

Leqvio is FDA-approved as an add-on to diet and exercise to lower LDL cholesterol in adults with hypercholesterolemia. It's also approved for heterozygous familial hypercholesterolemia in patients 12 and older, and for homozygous familial hypercholesterolemia in pediatric patients 12 and older.

  • Add-on to diet and exercise for high LDL cholesterol

  • Heterozygous familial hypercholesterolemia (ages 12+)

  • Homozygous familial hypercholesterolemia in pediatric patients 12+

Zocor vs. Leqvio Pros and Cons

Zocor

Zocor is a low-cost generic with decades of real-world use, making it an accessible first-line option for most people with high cholesterol. It requires daily dosing and carries a dose-dependent risk of muscle problems, particularly at higher doses or when combined with certain other medications.

Pros

  • Inexpensive generic tablet, widely covered by insurance

  • Decades of real-world safety data since 1991

  • Comes in four dose strengths for flexible titration

  • Taken as a simple daily pill, no injections needed

Cons

  • Requires daily dosing and consistent adherence

  • Risk of muscle pain (myalgia) and rare rhabdomyolysis

  • Interacts with many common medications (CYP3A4 inhibitors)

  • Higher doses require slow titration and monitoring

Leqvio

Leqvio offers infrequent dosing, two starter injections followed by just one shot every six months, which can help people who struggle with daily pills. It's a newer drug, must be given by a healthcare provider, and carries a small risk of hypersensitivity reactions including anaphylaxis.

Pros

  • Only two injections per year after the starter doses

  • Removes the burden of remembering a daily pill

  • Distinct siRNA mechanism, an option when statins aren't tolerated

  • No boxed warning on the current label

Cons

  • Must be given by a healthcare provider, not self-injected at home

  • Newer drug with less long-term safety data than Zocor

  • Risk of hypersensitivity reactions, including anaphylaxis

  • Not approved for homozygous FH in adults, only pediatric patients

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.